086450 — DongKook Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩838bn
- KR₩894bn
- KR₩812bn
- 74
- 53
- 69
- 77
Annual cashflow statement for DongKook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 57,880 | 52,916 | 54,757 | 48,871 | 62,336 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 32,912 | 16,641 | 18,491 | 23,612 | 21,394 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -46,786 | -42,251 | -51,515 | -51,774 | -35,914 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 59,108 | 44,654 | 40,909 | 41,793 | 76,091 |
| Capital Expenditures | -41,394 | -51,421 | -51,230 | -39,350 | -30,802 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -55,546 | 7,891 | 38,822 | -13,041 | -34,062 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -96,940 | -43,530 | -12,408 | -52,391 | -64,864 |
| Financing Cash Flow Items | -1,809 | -1,437 | 672 | -2,472 | -2,846 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22,959 | 29,733 | -39,792 | -2,298 | -22,305 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15,723 | 30,907 | -11,750 | -13,141 | -10,281 |